We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

RUA Life Sciences plc (RUA) ORD GBP0.05

Sell:10.50p Buy:11.00p 0 Change: No change
Market closed Prices as at close on 26 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:10.50p
Buy:11.00p
Change: No change
Market closed Prices as at close on 26 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:10.50p
Buy:11.00p
Change: No change
Market closed Prices as at close on 26 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

RUA Life Sciences plc is a United Kingdom-based holding company of a group of medical device businesses focused on the exploitation of long-term implantable biostable polymer (Elast-Eon). Elast-Eon's biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. The Company has four business units: RUA Contract Manufacture, RUA Biomaterials, RUA Vascular and RUA Structural Heart. RUA Contract Manufacture is an end-to-end contract developer and manufacturer of medical devices and implantable fabric specialist. It provides sub-contract manufacturing, assembly, packing and services to the medical device sector from its Class 7 and 8 cleanroom suites. RUA Biomaterials is a licensor of Elast-Eon polymers to the medical device industry. RUA Vascular is engaged in the commercialization of open surgical vascular grafts and patches. RUA Structural Heart is engaged in the development of polymeric leaflet systems for heart valves.

Contact details

Address:
2 Drummond Crescent, Irvine
AYRSHIRE
KA11 5AN
United Kingdom
Telephone:
+44 (01294) 317073
Website:
https://rualifesciences.com/

Important dates

Future events
There are no future events available.
Past events
Trading Announcement 30 October 2024 30/10/24
Trading Announcement 27 August 2024 27/08/24
AGM 27 August 2024 27/08/24
Final results 24 July 2024 24/07/24
Trading Announcement 05 April 2024 05/04/24
General meeting 18 December 2023 18/12/23
Interim results 18 December 2023 18/12/23

General stock information

EPIC:
RUA
ISIN:
GB0033360586
Market cap:
£6.67 million
Shares in issue:
62.06 million
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • William Brown
    Chief Executive Officer
  • Lachlan Smith
    Chief Financial Officer, Executive Director, Company Secretary
  • John Mckenna
    Director of Marketing, Executive Director

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.